Unrealized gain (loss) on equity investments
Neurocrine Biosciences·Business Segments·1 segment·Rolls up to Unrealized Gain (Loss) on Equity Securities
Breakdown
Segments
Business SegmentsView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|
| Business Segments | -$30.60M | -$6.70M | $30.60M | $25.30M |
| Total | -$30.60M | -$6.70M | $30.60M | $25.30M |